Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Nathan Connell: Rethinking the Role of Factor V in Hemostasis
Nov 21, 2026, 11:28

Nathan Connell: Rethinking the Role of Factor V in Hemostasis

Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on LinkedIn about a recent article by Megan P. Jewell et al., published in Blood, adding:

“A fascinating new paper in Blood that challenges how we think about coagulation.

I’m not a basic scientist, but elegant science like this reminds me just how oversimplified our traditional models of coagulation really are.

Jewell and colleagues demonstrate that factor V, traditionally considered a procoagulant, also has an important anticoagulant function, limiting tissue factor–initiated factor X activation independently of TFPIα, with particular relevance to hemophilia A.

It’s a striking reminder that our familiar models of the coagulation ‘cascade’ cannot fully capture the complex biochemical and biological pathways refined over millions of years of evolution.

It will be fascinating to see whether these insights can ultimately be translated into new therapeutic approaches for both bleeding and thrombotic disorders.

Congratulations to Megan Jewell, Keith Neeves, and the entire University of Colorado Anschutz Hemophilia and Thrombosis Center team on this elegant and thought-provoking work!”

Title: Factor V is an anticoagulant of the extrinsic pathway of coagulation and a modifier of thrombin generation in hemophilia A

Authors: Megan P. Jewell, Christine H. Baird, Dianne Thornhill, Zaina Ashour, Alexandra Bernal, Julie A. Peterson, Rachel Blomberg, Chelsea M. Magin, Alan E. Mast, Marilyn J. Manco-Johnson, Suzanne Sindi, Aaron L. Fogelson, Karin Leiderman, Shekhar Kumar, Dougald M. Monroe, Keith B. Neeves

Nathan Connell: Rethinking the Role of Factor V in Hemostasis

Other posts featuring Nathan Connel on Hemostasis Today.